IgA nephropathy trials in Croatia

3 of 3 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Croatia
  A clinical trial to learn about the long-term safety of FUB523 (zigakibart) in people with immunoglobulin A (IgA) nephropathy who have completed previous zigakibart trials

  Where

  Rijeka, Zagreb

  Age

  18 years and over

  People

  69 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2024-519638-22-00
• Phase 3Taking people
  A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  Where

  Grad Zagreb, Rijeka

  Age

  18 years and over

  People

  454 worldwide

  Run by

  Biogen

  See details and how to joinNCT06935357 · EU 2024-519345-30-00
• Phase 2/3Enrolling by invitation
  Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

  Where

  Split, Zagreb

  Age

  18 years and over

  People

  600 worldwide

  Run by

  Otsuka Pharmaceutical Development & Commercialization, Inc.

  See details and how to joinNCT05248659